Jan 6, 2026 07:16AM
Jan 6, 2026 07:15AM
Aug 13, 2025 04:15PM
Jul 9, 2025 04:30AM
Jul 9, 2025 04:30AM
Jun 11, 2025 04:19PM
Jun 11, 2025 04:17PM Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
Jun 4, 2025 10:29PM
May 21, 2025 07:22AM
May 7, 2025 04:45PM
Mar 26, 2025 06:34PM
Mar 20, 2025 11:43AM
Mar 20, 2025 03:00AM
Mar 20, 2025 03:00AM Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
Nov 13, 2024 04:05PM
May 20, 2024 08:25PM
May 20, 2024 08:25PM
Feb 29, 2024 04:05PM
Feb 29, 2024 04:05PM
Feb 26, 2024 05:52AM
Feb 26, 2024 04:25AM Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Feb 23, 2024 08:15PM
Feb 15, 2024 06:31AM
Feb 15, 2024 06:30AM
Feb 14, 2024 12:15PM
Jan 29, 2024 05:55AM Alvotech (ALVO) Reports Positive Top-Line Results from a Pharmacokinetic Study for AVT03
Jan 29, 2024 04:00AM
Jan 19, 2024 11:30AM
Jan 19, 2024 11:30AM
Jan 19, 2024 11:30AM
Jan 3, 2024 04:25AM
Jan 3, 2024 03:30AM
Nov 29, 2023 04:00AM Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Nov 28, 2023 04:15PM
Nov 14, 2023 07:02AM
Nov 14, 2023 07:00AM
Nov 14, 2023 07:00AM
Nov 14, 2023 07:00AM
Oct 12, 2023 04:00AM
Sep 25, 2023 04:00AM Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®
Sep 25, 2023 04:00AM
Aug 29, 2023 05:27AM
Aug 29, 2023 05:00AM
Jul 31, 2023 05:43AM
Jul 31, 2023 04:00AM
Jul 31, 2023 04:00AM
Jul 24, 2023 06:03AM Teva (TEVA) and Alvotech (ALVO) Provide Update on Partnership
Jul 24, 2023 04:00AM

1,155,319 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All